NewLeaf Symbiotics

Categories
Founded

2012

Leadership
  • Brent Smith, CEO
  • Steve Kahn, Co-Founder
Headquarters

St Louis, MO

Website

newleafsym.com

S2G North Star Interim Outcomes
  • Increased availability, accessibility, and/or affordability of healthier foods and nutrition-based solutions Jump to footnote 1
NewLeaf Symbiotics is a biological technology provider.

The company is a pioneer and global leader of Pink-Pigmented Facultative Methylotrophs (PPFMs) and methanotrophs, a closely related microbe. Ranging from row crops to specialty operations, NewLeaf is dedicated to a science-led, performance-driven and data-backed approach that delivers results to its partners and the growers they support.

Open Positions

Insights

News

Footnotes

  1. S2G North Star Interim Outcomes reflect areas of strategic alignment with our long-term impact goals. These outcomes are intended to illustrate the types of non-financial progress S2G seeks to support across its portfolio and do not represent company-specific metrics or outcomes. They are not a reflection of investment performance, actual or realized returns, or future financial results.